Wells Fargo & Company Arvinas, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Arvinas, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 41,610 shares of ARVN stock, worth $761,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,610

Previous 60,399 31.11%

Holding current value

$761,879

Previous $1.49 Million 46.4%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$17.83 - $28.04 $335,007 - $526,843	-18,789 Reduced 31.11%	41,610 $797,000
Q3 2024 Nov 13, 2024	SELL	$23.66 - $32.73 $512,451 - $708,899	-21,659 Reduced 26.39%	60,399 $1.49 Million
Q2 2024 Aug 13, 2024	BUY	$24.46 - $40.4 $132,597 - $219,008	5,421 Added 7.07%	82,058 $2.18 Million
Q1 2024 May 10, 2024	BUY	$36.38 - $52.31 $635,704 - $914,064	17,474 Added 29.54%	76,637 $3.16 Million
Q4 2023 Feb 09, 2024	SELL	$14.19 - $42.33 $25,981 - $77,506	-1,831 Reduced 3.0%	59,163 $2.44 Million
Q3 2023 Nov 13, 2023	SELL	$19.64 - $28.21 $328,734 - $472,178	-16,738 Reduced 21.53%	60,994 $1.2 Million
Q2 2023 Aug 15, 2023	BUY	$21.73 - $31.43 $213,975 - $309,491	9,847 Added 14.51%	77,732 $1.93 Million
Q1 2023 May 12, 2023	BUY	$26.15 - $37.26 $61,452 - $87,561	2,350 Added 3.59%	67,885 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $147,641 - $260,270	4,547 Added 7.46%	65,535 $2.24 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $110,243 - $152,687	2,633 Added 4.51%	60,988 $2.71 Million
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $981,668 - $2.02 Million	-27,261 Reduced 31.84%	58,355 $2.46 Million
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $505,906 - $684,698	-8,394 Reduced 8.93%	85,616 $5.76 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $865,137 - $1.26 Million	13,138 Added 16.25%	94,010 $7.72 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $1.59 Million - $2.34 Million	21,667 Added 36.6%	80,872 $6.65 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $30,225 - $42,130	500 Added 0.85%	59,205 $4.56 Million
Q1 2021 May 13, 2021	SELL	$58.19 - $91.37 $1.75 Million - $2.75 Million	-30,111 Reduced 33.9%	58,705 $3.88 Million
Q4 2020 Feb 09, 2021	SELL	$20.19 - $84.93 $82,597 - $347,448	-4,091 Reduced 4.4%	88,816 $7.54 Million
Q3 2020 Nov 05, 2020	BUY	$22.99 - $36.34 $43,359 - $68,537	1,886 Added 2.07%	92,907 $2.19 Million
Q2 2020 Aug 13, 2020	BUY	$29.88 - $56.74 $633,037 - $1.2 Million	21,186 Added 30.34%	91,021 $3.05 Million
Q1 2020 May 14, 2020	BUY	$33.0 - $54.5 $2.3 Million - $3.81 Million	69,835 New	69,835 $2.81 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

70.9M

Call Options Held

1.53M

Put Options Held

346K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $974M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Arvinas, Inc. Transaction History